• Home
  • About Us
    • Who Are We ?

    • Vision & Mission

    • Promoters
  • Manufacturing Sites
    • BLL (WHO-GMP) ------

    • Brooks Steriscience
  • Our Products
    • General Products   
      • Liquid Injection Ampoules

      • Liquid Injection Vials

      • Dry Powder Injection Vials

      • Lyophilized Injections

      • Eye/Ear Drops

      • Nasal Drops

    • β-Lactam Range  
      • Tablets

      • Dry Powder Syrup

      • Injection

    • Cephalosporin Range  
      • Tablets

      • Dry Powder Syrup

      • Injection
  • Sales & Marketing
    • India  
      • CCD

      • Institutional Business

      • CDMO Services

    • International  
      • Our Global Presence
  • Investors
    • Investors Forum

    • Committee Details
  • Contact Us
    • Product Enquiry

    • Investor Enquiry

    • Career Enquiry

Policies

Details of Business Disclaimer Financial Results Annual Report Annual Return MOA AOA Preferential Allotment List of Directors Shareholding Pattern Newspaper Advertisements Policies Notices Voting Results Disclosure Under Regulation-30 Secreterial Compliance Report Annual Reports of Subsidiary Companies Related Party Transaction Investors Contact Investor Forms Right Issue Prospectus Credit Rating

Policies

  • Criteria for making payment to Non executive Directors
  • Familiarization Programme of Independent Directors
  • Policy on materiality of related party transactions
  • Vigil Mechanism Brooks
  • Policy for Determining Material Subsidiaries
  • Nomination and Remuneration Policy for Directors, Key Managerial Personnel and other Employees
  • Detail of Familiarization Programme of Independent Directors
  • CSR Policy
  • Performance Evaluation Policy
  • Policy Determination of Materiality of Events
  • Documents Retention Archival Policy

  • Code of conduct

  • Code of conduct

    Appointment letter of independent directors

  • LOA Independent Director

    Code of practices and procedures for fair disclosure

  • Code of Practices and Procedures for Fair Disclosure
  • BSE Code - 533543
  • NSE Symbol - BROOKS
  • With roots dating back to 2002, Brooks Laboratories were established with a sole purpose of being a pioneer in the Pharmaceutical industry.
News & Articles
  • Events
Useful Links
  • Policy
  • Annual Reports
  • BLL(WHO-GMP)
  • Brooks Steriscience
Reach Us

Copyright © 2025 Brooks Laboratories. All right reserved. Designed by Sharptech Company